More than half of the stock market's post-Trump-election rally has been erased.
Vaccine stocks have struggled since RFK Jr.'s appointment to health secretary, with Moderna and Pfizer seeing the deepest losses.
Though Bank of America expects continued stock market upside, three risks could upend the rally.
